SOTERA HEALTH COMPANY Income Taxes Paid
SOTERA HEALTH COMPANY (SHC) reported Income Taxes Paid of $24.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-06
- SOTERA HEALTH COMPANY income taxes paid, net for the quarter ending 2026-06-30 was $14.96M, a 25.18% decline year-over-year.
- SOTERA HEALTH COMPANY income taxes paid, net for the quarter ending 2026-03-31 was $9.20M, a 24.68% decline year-over-year.
- SOTERA HEALTH COMPANY income taxes paid, net for the quarter ending 2025-12-31 was $13.27M, a 43.26% decline year-over-year.
- SOTERA HEALTH COMPANY income taxes paid, net for the quarter ending 2025-09-30 was $15.40M, a 4.53% increase year-over-year.
- SOTERA HEALTH COMPANY income taxes paid, net for fiscal 2025 was $60.87M, a 7.53% decline from fiscal 2024.
- SOTERA HEALTH COMPANY income taxes paid, net for fiscal 2024 was $65.83M, a 31.11% increase from fiscal 2023.
- SOTERA HEALTH COMPANY income taxes paid, net for fiscal 2023 was $50.21M, a 33.49% decline from fiscal 2022.
- SOTERA HEALTH COMPANY income taxes paid, net for fiscal 2022 was $75.50M, a 45.17% increase from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $24.16M 10-Q · filed 2026-08-06 | $37.42M derived: sum of 3 quarters · filed 2026-08-06 | $52.82M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $9.20M 10-Q · filed 2026-05-05 | $22.47M derived: sum of 2 quarters · filed 2026-05-05 | $37.87M derived: sum of 3 quarters · filed 2026-05-05 | $57.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $13.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $28.67M derived: sum of 2 quarters · filed 2026-02-24 | $48.66M derived: sum of 3 quarters · filed 2026-08-06 | $60.87M 10-K · filed 2026-02-24 |
| 2025-09-30 | $15.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $35.39M derived: sum of 2 quarters · filed 2026-08-06 | $47.61M 10-Q · filed 2025-11-04 | $70.99M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $19.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $32.21M 10-Q · filed 2026-08-06 | $55.59M derived: sum of 3 quarters · filed 2026-08-06 | $70.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $12.21M 10-Q · filed 2026-05-05 | $35.60M derived: sum of 2 quarters · filed 2026-05-05 | $50.33M derived: sum of 3 quarters · filed 2026-05-05 | $68.21M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $23.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $38.12M derived: sum of 2 quarters · filed 2026-02-24 | $55.99M derived: sum of 3 quarters · filed 2026-02-24 | $65.83M 10-K · filed 2026-02-24 |
| 2024-09-30 | $14.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $32.61M derived: sum of 2 quarters · filed 2025-11-04 | $42.45M 10-Q · filed 2025-11-04 | $50.07M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $17.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $27.71M 10-Q · filed 2025-08-08 | $35.34M derived: sum of 3 quarters · filed 2026-02-24 | $50.33M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $9.84M 10-Q · filed 2025-05-01 | $17.46M derived: sum of 2 quarters · filed 2026-02-24 | $32.46M derived: sum of 3 quarters · filed 2026-02-24 | $46.03M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $7.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $22.62M derived: sum of 2 quarters · filed 2026-02-24 | $36.20M derived: sum of 3 quarters · filed 2026-02-24 | $50.21M 10-K · filed 2026-02-24 |
| 2023-09-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $28.57M derived: sum of 2 quarters · filed 2024-11-05 | $42.59M 10-Q · filed 2024-11-05 | $61.61M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $13.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $27.59M 10-Q · filed 2024-08-05 | $46.61M derived: sum of 3 quarters · filed 2025-02-27 | $65.75M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $14.01M 10-Q · filed 2024-05-02 | $33.04M derived: sum of 2 quarters · filed 2025-02-27 | $52.17M derived: sum of 3 quarters · filed 2025-02-27 | $76.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $19.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $38.16M derived: sum of 2 quarters · filed 2025-02-27 | $61.99M derived: sum of 3 quarters · filed 2025-02-27 | $75.50M 10-K · filed 2025-02-27 |
| 2022-09-30 | $19.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $42.97M derived: sum of 2 quarters · filed 2023-11-01 | $56.47M 10-Q · filed 2023-11-01 | $76.56M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $23.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $37.34M 10-Q · filed 2023-08-03 | $57.42M derived: sum of 3 quarters · filed 2024-02-27 | $66.56M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $13.51M 10-Q · filed 2023-05-03 | $33.59M derived: sum of 2 quarters · filed 2024-02-27 | $42.73M derived: sum of 3 quarters · filed 2024-02-27 | $53.95M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $20.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $29.22M derived: sum of 2 quarters · filed 2024-02-27 | $40.45M derived: sum of 3 quarters · filed 2024-02-27 | $52.01M 10-K · filed 2024-02-27 |
| 2021-09-30 | $9.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $20.36M derived: sum of 2 quarters · filed 2022-11-02 | $31.92M 10-Q · filed 2022-11-02 | $46.26M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $11.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $22.79M 10-Q · filed 2022-08-04 | $37.12M derived: sum of 3 quarters · filed 2023-02-28 | $43.44M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $11.56M 10-Q · filed 2022-05-05 | $25.90M derived: sum of 2 quarters · filed 2023-02-28 | $32.22M derived: sum of 3 quarters · filed 2023-02-28 | $33.68M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $14.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $20.66M derived: sum of 2 quarters · filed 2023-02-28 | $22.12M derived: sum of 3 quarters · filed 2023-02-28 | $23.99M 10-K · filed 2023-02-28 |
| 2020-09-30 | $6.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $7.78M derived: sum of 2 quarters · filed 2021-11-10 | $9.65M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $3.33M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $1.87M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $44.61M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |